AME position statement: primary hyperparathyroidism in clinical practice.

Journal of endocrinological investigation

Volumn 35, Issue 7 Suppl, 2012, Pages 2-21

  Zini, Michele ^a   Attanasio, Roberto ^b   Cesareo, Roberto ^b   Emmolo, Ignazio ^b   Frasoldati, Andrea ^b   Gianotti, Laura ^b   Guglielmi, Rinaldo ^b   Piovesan, Alessandro ^b   Procopio, Massimo ^b   Scillitani, Alfredo ^b   Versari, Annibale ^b   Bollerslev, Jens ^b   Rao, Dhanwada Sudhaker ^b   Marcocci, Claudio ^b   Borretta, Giorgio ^b   Italian Association of Clinical Endocrinologists, ^b  

^a S MARIA NUOVA HOSPITAL   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; CALCIMIMETIC AGENT; PARATHYROID HORMONE;

ARTICLE; BLOOD; BONE DISEASE; FEMALE; HUMAN; KIDNEY DISEASE; MALE; PARATHYROIDECTOMY; PRACTICE GUIDELINE; PRIMARY HYPERPARATHYROIDISM; SEVERITY OF ILLNESS INDEX;

BONE DENSITY CONSERVATION AGENTS; BONE DISEASES; CALCIMIMETIC AGENTS; DIPHOSPHONATES; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; KIDNEY DISEASES; MALE; PARATHYROID HORMONE; PARATHYROIDECTOMY; SEVERITY OF ILLNESS INDEX;

EID: 84872047909     PISSN: None     EISSN: 17208386     Source Type: Journal    
DOI: None     Document Type: Article

References (0)